• 1
    Laaksonen DE, Niskanen L, Nyyssonen K, et al. Dyslipidemia as a predictor of hypertension in middle-aged men. Eur Heart J. 2008;29:25612568.
  • 2
    Liu J, Grundy SM, Wang W, et al. Ten-year risk of cardiovascular incidence related to diabetes, pre-diabetes, and the metabolic syndrome. Am Heart J. 2007;153:552558.
  • 3
    Boulon C, Lafitte M, Richeboeuf V, et al. Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significance. Am J Cardiol. 2006;98:14291434.
  • 4
    Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. Findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356359.
  • 5
    Duncan GE, Li SM, Zhou HX. Prevalence and trends of a metabolic syndrome phenotype among US adolescents, 1999–2000. Diabetes Care. 2004;27:24382443.
  • 6
    Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004;27:24442449.
  • 7
    Razzouk L, Muntner P. Ethnic, gender, and age-related differences in patients with the metabolic syndrome. Curr Hypertens Rep. 2009;11:127132.
  • 8
    National Institutes of Health. Third Report of the National Cholesterol Education Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary. Bethesda, MD: National Institutes of Health, 2001 (NIH publ. no. 01-3670).
  • 9
    Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735.
  • 10
    Keevil JG, Cullen MW, Gangnon R, et al. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002. Am Heart J. 2008;156:284291.
  • 11
    Ford ES. Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999–2008. J Diabetes. 2011;4:337347.
  • 12
    Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003;163:427436.
  • 13
    Sniderman AD, Holme I, Aastveit A, et al. Relation of age, the apolipoprotein B/A-1 ratio and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease. Am J Cardiol. 2007;100:217221.
  • 14
    Kraja AT, Borecki IB, North K, et al. Longitudinal and age trends of metabolic syndrome and its risk factors: the Family Heart Study. Nutr Metab. 2006;3:41.
  • 15
    Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report. 2009;13:17.
  • 16
    Johnson WD, Kroon JJ, Greenway FL, et al. Prevalence of risk factors for metabolic syndrome in adolescents. National Health and Nutrition Examination Survey (NHANES) 2001–2006. Arch Pediatr Adolesc Med. 2009;163:371377.